CIPLA
Cipla Limited
Pharmaceuticals
Share price
₹1,432
Market cap
₹1.2L Cr
1Y return
▼ 9%
A leading pharmaceutical manufacturer, Cipla develops and markets branded and generic formulations alongside active pharmaceutical ingredients across multiple therapeutic areas. Established in 1935, the company operates manufacturing facilities across India and internationally, serving both domestic and global markets. Cipla's distinctive strength lies in its integrated business model combining formulation development with API production, enabling cost-efficient drug manufacturing, distribution, and accessibility to patients worldwide.
Investors holding Cipla Limited
9.75%
2.96%
1.04%
Latest move
DSP Mutual FundExited
DSP Mutual Fund, which previously held a 1.78 percent stake in Cipla Limited, is no longer listed among its disclosed shareholders, indicating either a complete sale or a reduction in its holding to below the 1 percent reporting threshold.
Sign in to read more
Whales made 6 more moves in Cipla Limited
Sign in to see who is buying and selling.
Sign in to find out